List of Compounds.pdf
PDF 152 KB Posted
- Attached to
- Chemical Library Federal contract opportunity
- Solicitation number
- 75N95022Q00363
About this file
This document contains a Sources Sought Notice from the Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse. The notice seeks information on a vendor's capability to provide a specific library of 50 chemical compounds listed by name, CAS number, and quantity to increase the diversity of NCATS' chemical libraries. Responses were required to include organization details, place of manufacture, and confirmation the vendor can provide the entire list of compounds. The anticipated contract would make one award for delivery of all compounds within six months of order receipt. Responses were due by July 18, 2022 and were to be submitted electronically to the contracting officer.
View the file
Other files for this federal contract opportunity
| File | Type | Posted |
|---|---|---|
| List of Compounds_smiles.xlsx | XLSX spreadsheet | |
| List of Compounds_Revised.pdf |
On GovTribe
Work with this file on GovTribe
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Sources Sought Notice No. 75N95022Q00363
Required Compounds
N Compound name CAS# Quantity 1 Artilide fumarate 133267-20-6 1.0 g 2 Axelopran 949904-48-7 (free base) 1.0 g 3 Axitirome 156740-57-7 1.0 g 4 Beloxepin 135928-30-2 1.0 g 5 Budiodarone 335148-45-3 (free base) 1.0 g 6 Valomaciclovir stearate 195156-77-5 1.0 g 7 BI-44370 866086-05-7 1.0 g 8 alentemol 112891-97-1 1.0 g 9 Atigliflozin 647834-15-9 1.0 g
10 Befiperide 100927-14-8 1.0 g 11 apadoline 135003-30-4 1.0 g 12 Avitriptan 151140-96-4 (free base) 1.0 g 13 AZD-0328 220099-91-2 1.0 g 14 Adekalant tartrate 227940-00-3 1.0 g 15 AZD-2207 866598-45-0 1.0 g 16 A33903 70890-53-8 1.0 g 17 alifedrine HCl 72913-80-5 1.0 g 18 Azalanstat HCl 143484-82-6 1.0 g 19 Berupipam 150490-85-0 1.0 g 20 Adaprolol maleate 121009-31-2 1.0 g 21 Asobamast 104777-03-9 1.0 g 22 Bisaramil HCl 96480-44-3 1.0 g 23 abp-700 1446482-29-6 1.0 g 24 agn-201904 651729-53-2 1.0 g 25 Asulacrine free base 80841-47-0 (free base) 1.0 g 26 Atibeprone 153420-96-3 1.0 g 27 Belfosdil 103486-79-9 1.0 g 28 BMS-223131 275375-69-4 1.0 g 29 Vaneprim 81523-49-1 1.0 g 30 Batanopride 102670-46-2 1.0 g 31 Bromofosfamide 104149-14-6 1.0 g 32 P552-02 587879-32-1 1.0 g 33 Aroplatin 114488-24-3 1.0 g 34 AZD-1386 942937-80-6 1.0 g
35 Bemitradine 88133-11-3 1.0 g 36 NU-3 403717-06-6 1.0 g 37 aftobetin 1208971-05-4 1.0 g 38 agg-523 920289-29-8 1.0 g 39 anaxirone 77658-97-0 1.0 g 40 Bisnafide 144849-63-8 (free base) 1.0 g 41 AZD-8418 1198309-73-7 1.0 g 42 abaperidone 183849-43-6 1.0 g 43 alt-2074 173026-17-0 1.0 g 44 Bemoradan 112018-01-6 1.0 g 45 Bimakalim 117545-11-6 1.0 g 46 AZD1446 tosylate 938789-11-7 1.0 g 47 AZD-6703 851845-37-9 (free base) 1.0 g 48 Butantrone 75464-11-8 1.0 g 49 abt-925 220519-06-2 1.0 g 50 an-2898 906673-33-4 1.0 g 51 Atocalcitol 302904-82-1 5.0mg 52 AZD-8848 866269-28-5 (free base) 5mg
Salient Characteristics
1. Small molecules must have validated biological and pharmacological activities.
2. Must be available for high-throughput screening (HTS) and high-content screening (HCS).
3. Must come with detailed biological and chemical information with LC/MS and NMR reports to ensure high quality.
Sources Sought Notice No. 75N95022Q00363
File details come from the government source that posted it. Updated .